# Preventing Recurrent Gestational Diabetes With Metformin

> **NCT02394158** · PHASE4 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 112 (estimated)

## Conditions studied

- Gestational Diabetes Mellitus

## Interventions

- **DRUG:** Metformin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02394158
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01-27
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394158, "Preventing Recurrent Gestational Diabetes With Metformin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02394158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*